Alexander Levitzki
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 40
- Cytokine Signaling Pathways and Interactions 23
- Molecular Biology top 0.1%
- Receptor Mechanisms and Signaling 59
- Protein Kinase Regulation and GTPase Signaling 45
- PI3K/AKT/mTOR signaling in cancer 34
- Fungal and yeast genetics research 22
- Cell Biology top 0.2%
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 18
- Cancer Research top 0.5%
-
- Monoclonal and Polyclonal Antibodies Research 18
- Co-authors
- Aviv GazitChaim GilonDaniel E. KoshlandDavid EngelbergNir OsherovMoran BenharRichard JoveMichael L. Steer
- Journals
- Biochemistry (24 papers)Proceedings of the National Academy of Sciences (23 papers)Journal of Biological Chemistry (18 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Alexander Levitzki
326 papers receiving 21.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 5.9k
- Molecular Biology 14.3k
- Cell Biology 2.2k
- Hematology 1.4k
- Cancer Research 1.8k
Countries citing papers authored by Alexander Levitzki
This map shows the geographic impact of Alexander Levitzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Levitzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Levitzki more than expected).
Fields of papers citing papers by Alexander Levitzki
This network shows the impact of papers produced by Alexander Levitzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Levitzki. The network helps show where Alexander Levitzki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexander Levitzki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 13 | |
| 2 | 2018 | 14 | |
| 3 | 2014 | 32 | |
| 4 | 2014 | 6 | |
| 5 | 2013 | 101 | |
| 6 | 2011 | 2 | |
| 7 | 2010 | 28 | |
| 8 | 2007 | 25 | |
| 9 | 2004 | 8 | |
| 10 | 2004 | 31 | |
| 11 | 2003 | 51 | |
| 12 | 2003 | 69 | |
| 13 | High-performance liquid chromatographic analysis of the tyrphostin AG1478, a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in mouse plasma | 2001 | 1 |
| 14 | 1997 | 185 | |
| 15 | SRC as a target for anti-cancer drugs. | 1996 | 28 |
| 16 | 1993 | 35 | |
| 17 | 1993 | 164 | |
| 18 | 1991 | 69 | |
| 19 | 1991 | 62 | |
| 20 | Teatro, Mauá, SP. | 1991 | 97 |
About Alexander Levitzki
Alexander Levitzki is a scholar working on Molecular Biology, Oncology, Cell Biology, Physiology and Hematology, having authored 328 papers that have together received 22.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (59 papers), Protein Kinase Regulation and GTPase Signaling (45 papers), HER2/EGFR in Cancer Research (40 papers), PI3K/AKT/mTOR signaling in cancer (34 papers), Cytokine Signaling Pathways and Interactions (23 papers), Fungal and yeast genetics research (22 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). The work is most often cited by research in Oncology (5.9k citations), Molecular Biology (14.3k citations), Cell Biology (2.2k citations), Hematology (1.4k citations) and Cancer Research (1.8k citations). Alexander Levitzki has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Aviv Gazit, Chaim Gilon, Daniel E. Koshland, David Engelberg, Nir Osherov, Moran Benhar, Richard Jove, Michael L. Steer, Shoshana Klein and Aviva M. Tolkovsky. Their work appears in journals such as Biochemistry, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, FEBS Letters and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.